Ind-Swift Laboratories Limited (NSE:INDSWFTLAB)
India · Delayed Price · Currency is INR 138.01
-0.15 (-0.11%)
May 11, 2026, 3:29 PM IST
Ind-Swift Laboratories Market Cap
Ind-Swift Laboratories has a market cap or net worth of 12.01 billion as of May 11, 2026. Its market cap has increased by 133.40% in one year.
Market Cap
12.01B
Enterprise Value
8.04B
Revenue
5.94B
Ranking
n/a
PE Ratio
4.42
Stock Price
138.01
Market Cap Chart
Since June 1, 1999, Ind-Swift Laboratories's market cap has increased from 111.51M to 12.01B, an increase of 10,672.66%. That is a compound annual growth rate of 18.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 11.98B | 66.53% |
| Dec 31, 2025 | 7.19B | 12.14% |
| Dec 31, 2024 | 6.42B | 4.85% |
| Dec 29, 2023 | 6.12B | 49.10% |
| Dec 30, 2022 | 4.10B | 2.21% |
| Dec 31, 2021 | 4.01B | 9.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RPG Life Sciences | 40.74B |
| Orchid Pharma | 34.59B |
| Solara Active Pharma Sciences | 25.31B |
| Indoco Remedies | 21.04B |
| Windlas Biotech | 17.37B |
| Jagsonpal Pharmaceuticals | 14.59B |
| Beta Drugs | 13.35B |
| Sakar Healthcare | 12.14B |